AU2016901429A0 - Haloallylamine inhibitors of amine oxidases and uses thereof - Google Patents

Haloallylamine inhibitors of amine oxidases and uses thereof

Info

Publication number
AU2016901429A0
AU2016901429A0 AU2016901429A AU2016901429A AU2016901429A0 AU 2016901429 A0 AU2016901429 A0 AU 2016901429A0 AU 2016901429 A AU2016901429 A AU 2016901429A AU 2016901429 A AU2016901429 A AU 2016901429A AU 2016901429 A0 AU2016901429 A0 AU 2016901429A0
Authority
AU
Australia
Prior art keywords
amine oxidases
haloallylamine
inhibitors
haloallylamine inhibitors
oxidases
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2016901429A
Inventor
Alberto Buson
Mandar Deodhar
Alison Dorothy Findlay
Jonathan Stuart Foot
Wolfgang JAROLIMEK
Alan Duncan Robertson
Craig Ivan Turner
Wenbin ZHOU
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pharmaxis Ltd
Original Assignee
Pharmaxis Ltd
Filing date
Publication date
Application filed by Pharmaxis Ltd filed Critical Pharmaxis Ltd
Publication of AU2016901429A0 publication Critical patent/AU2016901429A0/en
Abandoned legal-status Critical Current

Links

AU2016901429A 2016-04-18 Haloallylamine inhibitors of amine oxidases and uses thereof Abandoned AU2016901429A0 (en)

Publications (1)

Publication Number Publication Date
AU2016901429A0 true AU2016901429A0 (en) 2016-04-28

Family

ID=

Similar Documents

Publication Publication Date Title
EP3700527A4 (en) Papd5 inhibitors and methods of use thereof
EP3429591A4 (en) Substituted inhibitors of menin-mll and methods of use
EP3684361A4 (en) Substituted inhibitors of menin-mll and methods of use
EP3526222A4 (en) Tyk2 inhibitors and uses thereof
EP3528816A4 (en) Tyk2 inhibitors and uses thereof
EP3510040A4 (en) Ectonucleotidase inhibitors and methods of use thereof
EP3658557A4 (en) Tyk2 inhibitors and uses thereof
EP3541932A4 (en) Inhibitors of crispr-cas9
EP3600318A4 (en) Methods of using ehmt2 inhibitors
EP3454945A4 (en) Ash1l inhibitors and methods of treatment therewith
EP3558998A4 (en) Ectonucleotidase inhibitors and methods of use thereof
AU2015342774B2 (en) EZH2 inhibitors and uses thereof
EP3344039A4 (en) Small molecule inhibitors of dyrk1a and uses thereof
EP3445365A4 (en) Ezh2 inhibitors and uses thereof
EP3558303A4 (en) Amino acid compounds and methods of use
EP3509591A4 (en) Novel jak1 selective inhibitors and uses thereof
EP3435956A4 (en) Photo-stabilized compositions and methods of use
EP3572400A4 (en) Ezh2 inhibitor and use thereof
EP3710430A4 (en) Acss2 inhibitors and methods of use thereof
EP3592731A4 (en) Inhibitors of malt1 and uses thereof
EP3352754A4 (en) Aldose reductase inhibitors and methods of use thereof
EP3706737A4 (en) Ash1l inhibitors and methods of treatment therewith
EP3635000A4 (en) Manabodies and methods of using
EP3177327A4 (en) Inhibitors of myh7b and uses thereof
EP3506982A4 (en) Mif inhibitors and methods of use thereof